Cardiva Medical to Present at the Jefferies 2019 Healthcare Conference
June 3, 2019SANTA CLARA, Calif. & NEW YORK–(BUSINESS WIRE)–Cardiva Medical, Inc., an innovator in the field of vascular closure,
today announced that John Russell, president and chief executive officer
of Cardiva Medical, is scheduled to present a corporate overview at the
Jefferies 2019 Healthcare Conference on Wednesday, June 5, 2019 at 4:30
p.m. EST in New York, NY.
About Cardiva Medical, Inc.
Cardiva Medical, Inc. is a privately held medical device company focused
on developing and commercializing innovative vascular closure
technologies.
The Company’s VASCADE® Vascular Closure System has been PMA
approved by the FDA since 2013 and is indicated for vessel closure
following 5-7F arterial and venous procedures. VASCADE is the only
closure system to demonstrate a statistically significant reduction in
access site complications compared to the existing standard of care in a
prospective, randomized, controlled clinical trial called RESPECT. The
latest product in the Company’s portfolio is VASCADE® MVP
Venous Vascular Closure System, which is the first vessel closure
technology designed specifically for Electrophysiology procedures – and
proven by Electrophysiology physicians in the multi-center, randomized,
controlled clinical trial called AMBULATE. VASCADE MVP received PMA
approval in late 2018.
Cardiva has won numerous recent awards for clinical, commercial and
operational excellence – including the Shingo Bronze Medallion and the
MedTech Insight Award – and is on the 2018 Inc 5000 list of the fastest
growing private companies in the United States. The Company is
headquartered in Santa Clara, California.
For further information, visit our website at www.cardivamedical.com
and follow us on Twitter at @CardivaMedical. VASCADE® and
Cardiva Catalyst® are registered trademarks of Cardiva Medical®,
Inc.
Contacts
Investor Contact:
Lisa Garrett
Chief Financial Officer,
Cardiva Medical, Inc.
[email protected]
408-470-7170
Media Contact:
Sierra Smith
[email protected]
408-540-4296